News Focus
News Focus
icon url

Work Harder

08/23/20 5:21 PM

#19875 RE: bow-tie #19874

Their approach is highly modular, based on the simple and rapid combination of a mesoporous silica material, an adjuvant, the dendritic cell-recruiting factor GM-CSF, and one or more antigen(s). Many different antigens and adjuvants can be combined in a plug-and-play fashion.

https://www.nature.com/articles/s41541-020-0190-9

In vitro and in vivo virosome uptake
Human cord blood CD34+ precursor cells were cultured one week with 50?ng/mL of GM-CSF and 5?ng/mL of IL-4 (from Miltenyi Biotec) for differentiation in DCs7

30.
Buchbinder, S. P. et al. Immunogenicity of a novel Clade B HIV-1 vaccine combination: results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults. PLoS ONE 12, e0179597 (2017).
icon url

Work Harder

08/23/20 6:01 PM

#19876 RE: bow-tie #19874

icon url

Work Harder

08/23/20 6:16 PM

#19877 RE: bow-tie #19874

The platform, which is known as OMNIVAX and is sponsored by the BMGF, aims to reduce the per-dose price of the trivalent poliovirus vaccine from around $2 to $0.15.

More recently, Batavia has been working with Univercells and Merck to create a low-cost manufacturing platform that will significantly ease the cost of global health vaccines.

The company has state-of-the-art laboratory infrastructure in both the Netherlands and the US, and is well equipped to develop any biopharmaceutical – be it an antibody, recombinant protein or vaccine – from early discovery all the way through to clinical manufacturing.

https://www.theneweconomy.com/technology/a-fairy-godmother-for-research-and-development-in-biopharmaceuticals

https://www.bataviabiosciences.com/
icon url

Work Harder

08/23/20 6:37 PM

#19879 RE: bow-tie #19874

Multiple drugs -

AdisInsightadisinsight.springer.com › drugsafety
May 7, 2017 - Influenza virus vaccine intranasal - Mymetics, Phase I, Mymetics Corporation ... Poliovirus vaccine inactivated - Batavia Biosciences, Preclinical

Link doesn't open

https://adisinsight.springer.com/drugsafety/803240307

A Chit Fighter - Chartered Accountant - Mymetics ... - ??

https://www.linkedin.com/authwall?trk=ripf&trkInfo=AQHhS8-0J-ojzgAAAXQdd2jYqt6My1yqCkW55VGECZ0NTAkQOuHy6FRpo7JrQJEKpz8RMlscZq-rr78Bg9BP6M0HWlK__kMmwkVUFbscqTME52SAZPeFQ1Ukg9dFTxGw51wM0z0=&originalReferer=https://www.google.com/&sessionRedirect=https%3A%2F%2Fcn.linkedin.com%2Fin%2Fa-chit-fighter-ba9b22136

Mymetics CorporationMyanmar Institute of Information Technology (MIIT). ??????2 ? ... Matthijs Baart. Virologist & BioRisk Officer at Batavia Biosciences.

Yeow right, warerver

LOL
icon url

Work Harder

08/23/20 6:40 PM

#19880 RE: bow-tie #19874

Batavia to manufacture IAVI's replication-competant VSV for the treatment of COVID-19 infection, Marburg and Ebola virus infection International AIDS Vaccine Initiative Batavia Biosciences BV Payment unspecified 3/5/20

Batavia to manufacture and distribute Wistar's rubella vaccine seed stock RA 27/3 worldwide Batavia Biosciences BV Wistar Institute of Anatomy & Biology Payment unspecified 4/29/20

https://www.bioworld.com/biopharma-nonprofit-collaborations-2020

Small world Harvard & Wyss works in

https://www.google.com/maps/dir/Mymetics+B.V.,+J.H.+Oortweg,+Leiden,+Netherlands/Batavia+Biosciences+B.V.,+Zernikedreef+16,+2333+CL+Leiden,+Netherlands/@52.1680097,4.4638038,17z/data=!3m1!4b1!4m13!4m12!1m5!1m1!1s0x47c5c71fc37b7e4b:0xae33d5031fcd8249!2m2!1d4.4652569!2d52.16894!1m5!1m1!1s0x47c5c6e108852819:0x92661631a5eeb8f3!2m2!1d4.4667178!2d52.1667448

What time is the BBQ Friday ?

LMAO